Concepedia

David Bernstein

DB

Statistics

Publications

30

Citations

4.1K

H-Index

24

Active since

1994

Affiliations

North Shore University Hospital(Current)

University of Miami

University of Pennsylvania

Texas Liver Institute

AbbVie (United States)

David Bernstein is an author at North Shore University Hospital specializing in viral hepatitis, pharmacotherapy, and pharmacy.

Publications per year

1994–2019

30

Publications

30

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV

Péter Ferenci, David Bernstein, Jacob Lalezari et al. · New England Journal of Medicine · 2014 · 695 citations · Full text

, , +16

All‐oral 12‐week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY‐3 phase III study

David R. Nelson, James N. Cooper, Jacob Lalezari et al. · Hepatology · 2015 · 689 citations · Full text

, , +15

Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial

Eric Lawitz, Jay Lalezari, Tarek Hassanein et al. · The Lancet Infectious Diseases · 2013 · 328 citations

, , +16

A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy

Douglas K. Rex, Raj Bhandari, Taddese Desta et al. · Gastrointestinal Endoscopy · 2018 · 304 citations · Full text

, , +6

Antituberculosis Drug–induced Hepatotoxicity: The Role of Hepatitis C Virus and the Human Immunodeficiency Virus

Jaime Ungo, Denis Jones, David Ashkin et al. · American Journal of Respiratory and Critical Care Medicine · 1998 · 292 citations

, , +9

1–5 of 30